LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication. The feature is expected to be published in the July 2026 edition and will include an editorial profile and interview discussing the Company's healthcare technology initiatives, digital healthcare ecosystem strategy, and ongoing efforts to improve healthcare accessibility throughout Latin America.
The Company noted that it has received a formal invitation from the publisher to participate in a broader editorial feature package, which is expected to include coverage through both ES Salud Magazine and Eva's Magazine. According to the invitation, the feature is anticipated to be distributed through multiple print, digital, social media, and online publication channels. This multi-channel distribution is expected to significantly amplify the Company's message and reach a wider audience of healthcare professionals and industry participants.
Management stated that the publication provides an opportunity to discuss LataMed AI's evolving healthcare platform while increasing visibility of its healthcare ecosystem among healthcare professionals, industry participants, and other stakeholders. The feature is expected to discuss the Company's telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions currently under development. These discussions will highlight LataMed AI's broader vision of developing an integrated healthcare ecosystem designed to improve accessibility, coordination, and engagement for patients, healthcare providers, and other stakeholders across emerging markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We appreciate the opportunity to share our vision for technology-enabled healthcare solutions and discuss the initiatives we are currently advancing throughout Latin America. We believe healthcare accessibility, coordination, and patient engagement remain important challenges across many markets, and we welcome opportunities to participate in industry discussions regarding the role of technology in addressing those challenges. We also believe opportunities to engage with healthcare-focused audiences help increase awareness of our broader healthcare ecosystem strategy and the technologies we are developing to support patients and providers throughout Latin America."
The announcement underscores the importance of industry-specific publications in raising awareness about healthcare innovation. For a development-stage company like LataMed AI, visibility in a reputable healthcare magazine can attract potential partners, investors, and customers. It also serves as a validation of the Company's efforts and strategy, providing a platform to share perspectives on evolving healthcare technologies and engage with key stakeholders. The Company expects the feature to be published during July 2026 and intends to provide additional updates once publication details have been finalized, including information regarding publication dates, online availability, print distribution, and access through the publication's online digital channels.
For additional information, please visit https://latamed.ai or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
